sargramostim

pharmaceutical drug

Facts

8 properties
Instance of
type of chemical entity
Subclass of
leukocyte growth factor, granulocyte-macrophage colony-stimulating factor, recombinant protein[2][3][4]
Defined daily dose
0.45 mg[14]
Has characteristic
biopharmaceutical[6]
Subject has role
immunologic factor[13]
🏷️ Also known as
en sargramostim en B1 61.012 en Leukine en recombinant GM-CSF ar سارغراموستيم ja サルグラモスチム uk сарграмостим zh 沙格司亭
🔖 Identifiers · 15
ATC code
L03AA09
ChEMBL ID
CHEMBL1201670
DrugBank ID
DB00020
Encyclopædia Britannica Online ID
science/sargramostim
Freebase ID
/m/02wvcjd
Guide to Pharmacology Ligand ID
7905
MeSH descriptor ID
C081222
MedlinePlus drug identifier
a693005
Microsoft Academic ID (discontinued)
2776186052
NCI Drug Dictionary ID
sargramostim
NDF-RT ID
N0000147658
PatientsLikeMe treatment ID
1889, sargramostim
Show all 15 identifiers +3
RxNorm CUI
69634
WikiProjectMed ID
Sargramostim

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
← Drug or therapy used for treatment 3
Medical condition treated 2
Different from 1
Has characteristic 1
Has use 1
← Different from 1
Press Enter · cited answer in seconds

Summary

sargramostim is a type of chemical entity[1].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . NDF-RT. Retrieved . wikidata.org.
  2. [3] ↑ . NDF-RT. Retrieved . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . DrugBank. wikidata.org.
  5. [6] ↑ . DrugBank. wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . NDF-RT. Retrieved . wikidata.org.
  8. [9] ↑ . NDF-RT. Retrieved . wikidata.org.
  9. [10] ↑ . NDF-RT. Retrieved . wikidata.org.
  10. [11] ↑ . NDF-RT. Retrieved . wikidata.org.
  11. [12] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  12. [13] ↑ . NDF-RT. Retrieved . wikidata.org.
  13. [14] ↑ . whocc.no. whocc.no. Provenance: wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). sargramostim. Retrieved November 18, 2026, from https://4ort.xyz/entity/sargramostim
MLA “sargramostim.” 4ort.xyz Knowledge Graph, 4ort.xyz, 18 Nov. 2026, https://4ort.xyz/entity/sargramostim.
BibTeX @misc{4ortxyz_sargramostim_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{sargramostim}}, year = {2026}, url = {https://4ort.xyz/entity/sargramostim}, note = {Accessed: 2026-11-18}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): sargramostim — https://4ort.xyz/entity/sargramostim (retrieved 2026-11-18)

Canonical URL: https://4ort.xyz/entity/sargramostim · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 5w ago · KrBot bot · 2026-10-10 view diff on Wikidata ↗
    Subject has role → immunologic factor
    Medical condition treated → lymphosarcoma, lymphoid leukemia, Hodgkin's lymphoma, mixed cellularity +1
    Has characteristic → biopharmaceutical
    Instance of → type of chemical entity
    + 5 other properties edited (see Wikidata diff for full list)
    "Changed claim: Subclass of: recombinant protein, разрешение перенаправления / resolving redirect recombinant protein → recombinant protein ()"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.